Effect Modification by Indication to the Risks of Major Thromboembolic Adverse Events in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Treatment: A Population-Based Retrospective Cohort Study
Wan‐Ju Annabelle Lee, Shih‐Chieh Shao, Tzu‐Chi Liao, Swu‐Jane Lin, Chi‐Chun Lai, Edward Chia‐Cheng Lai
Topics & Concepts
RanibizumabAfliberceptMedicineMacular degenerationRetrospective cohort studyHazard ratioInternal medicineStroke (engine)OphthalmologyAdverse effectProportional hazards modelCentral retinal vein occlusionBevacizumabMacular edemaVisual acuityConfidence intervalMechanical engineeringEngineeringChemotherapyRetinal Diseases and TreatmentsRetinal and Optic ConditionsOcular Diseases and Behçet’s Syndrome